Identification of a conserved motif required for mTOR signaling

Stefanie S Schalm1, John Blenis

  • 1Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.

Current Biology : CB
|April 23, 2002
PubMed
Abstract

Insights

Researchers discovered a conserved TOR signaling (TOS) motif in S6 kinases and 4E-binding proteins. This motif is essential for regulating protein activity by the mTOR pathway, acting as a docking site for mTOR signaling.

Area of Science:

  • Cellular Biology
  • Molecular Biology
  • Signal Transduction

Background:

  • The mammalian target of rapamycin (mTOR) pathway regulates protein synthesis.
  • mTOR controls S6 kinases (S6K1/2) activation and eukaryotic initiation factor 4E (eIF4E) binding proteins (4E-BP1/2/3) inhibition.
  • The precise molecular mechanisms of mTOR regulation on S6K1 and 4E-BP1 are debated.

Purpose of the Study:

  • To identify the molecular basis of mTOR pathway regulation on S6K1 and 4E-BP1.
  • To investigate the role of conserved sequence motifs in mTOR signaling.
  • To elucidate the mechanism by which mTOR controls translation machinery.

Main Methods:

  • Sequence analysis to identify conserved motifs.
  • Site-directed mutagenesis of identified motifs in S6K1 and 4E-BP1.
  • Phosphorylation assays to assess protein activity.
  • Overexpression studies to evaluate pathway regulation.

Main Results:

  • A conserved TOR signaling (TOS) motif was identified in S6 kinases and 4E-binding proteins.
  • Mutations or deletions in the TOS motif impaired S6K1 activation and Thr389 phosphorylation.
  • The TOS motif is critical for S6K1 activation by mTOR and is required for suppressing C-terminal inhibitory activity.
  • Overexpression of S6K1 with an intact TOS motif prevented 4E-BP1 phosphorylation.

Conclusions:

  • A conserved five-amino acid TOS motif is crucial for mTOR pathway regulation of S6K1 and 4E-BP1.
  • The TOS motif likely functions as a docking site for mTOR or a common upstream activator.
  • mTOR employs distinct mechanisms to regulate S6K1, involving the TOS motif.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...